54 results
Page 2 of 3
8-K
EX-10.1
2si2t7u
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B5
lp0b4es3rcrbxvk
3 Jun 22
Prospectus supplement for primary offering
9:45pm
8-K
EX-99.1
7l61q2
28 Apr 22
Regulation FD Disclosure
2:35pm
424B3
hzun23 8r
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-99.1
eot4j77
21 Apr 22
Regulation FD Disclosure
2:46pm
424B3
z6cp61w5m68fvyy
7 Apr 22
Prospectus supplement
4:46pm
S-3
ov9ou7miqcm
4 Feb 22
Shelf registration
4:36pm
DEF 14A
vub3cklhsx niy
28 Oct 21
Definitive proxy
3:07pm
424B3
xenll1sx
22 Jul 21
Prospectus supplement
10:27am
8-K
EX-99.1
qnvd23le728iww t3
29 Jun 21
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
3:12pm
8-K
EX-99.1
t6z kiy3siye
17 Jun 21
Regulation FD Disclosure
1:19pm
8-K
EX-99.1
w8u5m g9flbeyg
13 May 21
InMed Pharmaceuticals Reports Third Quarter Fiscal 2021 Financial Results
4:23pm
8-K
EX-99.1
cpocey88ec6
27 Apr 21
Regulation FD Disclosure
4:22pm
424B3
e74yimkfus2sjv5tkdn
16 Mar 21
Prospectus supplement
12:00am
8-K
EX-99.1
81s 251yfq5i4
12 Feb 21
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results
12:35pm
8-K
EX-99.1
euyts24isq20zwo1c
11 Jan 21
Regulation FD Disclosure
6:03am